241 related articles for article (PubMed ID: 31340683)
1. Pharmacodynamics of current and emerging treatments for cervical cancer.
Duenas-Gonzalez A; Gonzalez-Fierro A
Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):671-682. PubMed ID: 31340683
[No Abstract] [Full Text] [Related]
2. Emerging drugs for the treatment of cervical cancer.
Serrano-Olvera A; Cetina L; Coronel J; Dueñas-González A
Expert Opin Emerg Drugs; 2015 Jun; 20(2):165-82. PubMed ID: 25578210
[TBL] [Abstract][Full Text] [Related]
3. The safety of drug treatments for cervical cancer.
Dueñas-González A; Cetina L; Coronel J; González-Fierro A
Expert Opin Drug Saf; 2016; 15(2):169-80. PubMed ID: 26650333
[TBL] [Abstract][Full Text] [Related]
4. [The guidelines for diagnostics and treatment of cervical cancer].
Inciūra A; Juozaityte E
Medicina (Kaunas); 2004; 40(4):394-403. PubMed ID: 15111756
[TBL] [Abstract][Full Text] [Related]
5. Integrating Chemotherapy in the Management of Cervical Cancer: A Critical Appraisal.
Kumar L; Gupta S
Oncology; 2016; 91 Suppl 1():8-17. PubMed ID: 27464068
[TBL] [Abstract][Full Text] [Related]
6. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS
Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837
[TBL] [Abstract][Full Text] [Related]
7. New pharmacotherapy options for cervical cancer.
Dueñas-Gonzalez A; Cetina L; Coronel J; Cano C; Dolores R
Expert Opin Pharmacother; 2014 Jan; 15(1):51-60. PubMed ID: 24206031
[TBL] [Abstract][Full Text] [Related]
8. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
9. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma].
Nöel G; Mazeron JJ
Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699
[No Abstract] [Full Text] [Related]
10. Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.
Chou HH; Huang HJ; Lin H; Yang LY; Hsueh S; Liu FY; Liou YL; Liou JD; Chen MY; Chao A; Lin G; Chang TC; Lai CH
Am J Clin Oncol; 2017 Jun; 40(3):241-249. PubMed ID: 25350466
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
Angioli R; Plotti F; Montera R; Aloisi A; Luvero D; Capriglione S; Terranova C; De Cicco Nardone C; Muzii L; Benedetti-Panici P
Gynecol Oncol; 2012 Nov; 127(2):290-6. PubMed ID: 22819938
[TBL] [Abstract][Full Text] [Related]
12. Modern management of locally advanced cervical carcinoma.
Dueñas-Gonzalez A; Cetina L; Mariscal I; de la Garza J
Cancer Treat Rev; 2003 Oct; 29(5):389-99. PubMed ID: 12972357
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy in the management of cervical carcinoma.
duPont NC; Monk BJ
Clin Adv Hematol Oncol; 2006 Apr; 4(4):279-86. PubMed ID: 16728939
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.
Vizza E; Corrado G; Zanagnolo V; Tomaselli T; Cutillo G; Mancini E; Maggioni A
Gynecol Oncol; 2014 May; 133(2):180-5. PubMed ID: 24589412
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
Li L; Song X; Liu R; Li N; Zhang Y; Cheng Y; Chao H; Wang L
BMC Cancer; 2016 Jul; 16():403. PubMed ID: 27387204
[TBL] [Abstract][Full Text] [Related]
17. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
Tambaro R; Scambia G; Di Maio M; Pisano C; Barletta E; Iaffaioli VR; Pignata S
Crit Rev Oncol Hematol; 2004 Oct; 52(1):33-44. PubMed ID: 15363465
[TBL] [Abstract][Full Text] [Related]
18. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
Ferrandina G; Palluzzi E; Gallotta V; Gambacorta MA; Autorino R; Turco LC; Macchia G; Cosentino F; Gui B; Mattoli MV; Ronzino G; Valentini V; Scambia G
Eur J Surg Oncol; 2018 Jul; 44(7):1062-1068. PubMed ID: 29753611
[TBL] [Abstract][Full Text] [Related]
19. Combinational therapies for the treatment of advanced cervical cancer.
Duenas-Gonzalez A
Expert Opin Pharmacother; 2023 Jan; 24(1):73-81. PubMed ID: 35653267
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]